Domino Vilsmeier-Haack/ring closure sequences: A facile synthesis of 3-chlorobenzo[b]thiophene-2-carbaldehydes

Tetrahedron Letters

Volumn 52, Issue 29, 2011, Pages 3743-3746

  Paul, Nidhin ^a   Muthusubramanian, Shanmugam ^a  

^a MADURAI KAMARAJ UNIVERSITY   (India)

Author keywords

2 (2 Oxo 2 arylethyl)sulfanyl 1 aryl 1 ethanones; Benzo b thiophene; Domino reaction; Vilsmeier Haack reaction

Indexed keywords

ALDEHYDE DERIVATIVE; BENZOTHIOPHENE DERIVATIVE;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CHEMICAL STRUCTURE; CYCLIZATION; PROTON NUCLEAR MAGNETIC RESONANCE; RING CLOSING METATHESIS; SYNTHESIS; VILSMEIER HAACK REACTION;

EID: 79959268953     PISSN: 00404039     EISSN: 18733581     Source Type: Journal    
DOI: 10.1016/j.tetlet.2011.05.046     Document Type: Article

References (80)

1. (a) Jutz, C. In Advances in Organic Chemistry In Iminium Salts in Organic Chemistry Part I; Taylor, E. C., Ed.; John Wiley: New York, 1976; 9, pp 225-342;
2. (b) Meth-Cohn, O.; Stanforth, S. P. In Comprehensive Organic Synthesis; Trost, B. M., Fleming, I., Eds.; Pergamon Press: New York, 1990; 2, pp 777-794;
3. (c) Marson, C. M. Tetrahedron 1992, 48, 3659;
4. (d) Jones, G.; Stanforth, S. P. Org. React. 2000, 56, 355.
5. (a) Quiroga, J.; Trilleras, J.; Insuasty, B.; Abonia, R.; Nogueras, M.; Cobo, J. Tetrahedron Lett. 2008, 49, 2689;
6. (b) Low, J. N.; Cobo, J.; Trilleras, J.; Glidewell, C. Acta Crystallogr., Sect. E 2006, 62, 4930;
7. (c) Trilleras, J.; Quiroga, J.; Low, J. N.; Cobo, J.; Glidewell, C. Acta Crystallogr., Sect. C 2008, 64, 341;
8. (d) Brahma, S.; Ray, J. K. Tetrahedron 2008, 64, 2883;
9. (e) Paul, S.; Gupta, M.; Gupta, R.; Loupy, A. Tetrahedron Lett. 2001, 42, 3827;
10. (f) Becher, J.; Olesen, P. H.; Knudsen, N. A.; Toftlund, H. Sulfur Lett. 1986, 4, 175;
11. (g) Zhu, D.-G.; Gunawardana, I. W.; Boyd, S. A.; Melcher, L. M. J. Heterocycl. Chem. 2008, 45, 91;
12. (h) Ivanov, I. C.; Glasnov, T. N.; Belaj, F. J. Heterocycl. Chem. 2008, 45, 177;
13. (i) Choudhury, A.; Cheng, H.; Nilsen, C. N.; Sorgi, K. L. Tetrahedron Lett. 2008, 49, 102;
14. (j) Hegab, M. I.; Abdel-Fattah, A.-S. M.; Yousef, N. M.; Nour, H. F.; Mostafa, A. M.; Ellithey, M. Arch. Pharm. 2007, 340, 396;
15. (k) Hegab, M. I.; Abdulla, M. M. Arch. Pharm. Chem. 2006, 339, 41;
16. (l) Ortiz, A.; Insuasty, B.; Torres, M. R.; Herranz, M. A.; Martin, N.; Viruela, R.; Orti, E. Eur. J. Org. Chem. 2008, 99.
17. (a) Lilienkampf, A.; Johansson, M. P.; Wahala, K. Org. Lett. 2003, 5, 3387;
18. (b) Tang, X.-Y.; Shi, M. J. Org. Chem. 2008, 73, 8317;
19. (c) Perumal, P. T. Indian J. Heterocycl. Chem. 2001, 11, 1;
20. (d) Pan, W.; Dong, D.-W.; Liu, Q. Org. Lett. 2007, 9, 2421;
21. (e) Wang, K.-W.; Xiang, D.-X.; Dong, D.-W. Org. Lett. 2008, 10, 1691;
22. (f) Chen, L.; Zhao, Y.-L.; Liu, Q.; Cheng, C.; Piao, C.-R. J. Org. Chem. 2007, 72, 9259;
23. (g) Zhang, R.; Zhang, D.; Guo, Y.; Zhou, G.; Jiang, Z.; Dong, D. J. Org. Chem. 2008, 73, 9504;
24. (h) Wuts, P. G. M.; Northuis, J. M.; Kwan, T. A. J. Org. Chem. 2000, 65, 9223;
25. (i) Xiang, D.; Yang, Y.; Zhang, R.; Liang, Y.; Pan, W.; Huang, J.; Dong, D. D. J. Org. Chem. 2007, 72, 8593;
26. (j) Mahata, P. K.; Venkatesh, C.; Syam Kumar, U. K.; Ila, H.; Junjappa, H. J. Org. Chem. 2003, 68, 3966;
27. (k) Meth-Cohn, O. Heterocycles 1993, 35, 539.
28. (a) Jeong, S.-J.; Higuchi, R.; Miyamoto, T.; Ono, M.; Kuwano, M.; Mawatari, S. F. J. Nat. Prod. 2002, 65, 1344;
29. (b) Kelly, T. R.; Fu, Y.; Sieglen, J. T.; De Silva, H. Org. Lett. 2000, 2, 2351.
30. (a) Jones, C. D.; Jevnikar, M. G.; Pike, A. J.; Peters, M. K.; Black, L. J.; Thompson, A. R.; Falcone, J. F.; Clemens, J. A. J. Med. Chem. 1984, 27, 1057;
31. (b) Bradley, D. A.; Godfrey, A. G.; Schmid, C. R. Tetrahedron Lett. 1999, 40, 5155;
32. (c) Palkowitz, A. D.; Glasebrook, A. L.; Thrascher, K. J.; Hauser, K. L.; Short, L. L.; Phillips, D. L.; Muehl, B. S.; Sato, M.; Shetler, P. K.; Cullinan, G. J.; Pell, T. R.; Bryant, H. U. J. Med. Chem. 1997, 40, 1407;
33. (d) Chen, Z.; Mocharla, V. P.; Farmer, J. M.; Pettit, G. R.; Hamel, E.; Pinney, K. G. J. Org. Chem. 2000, 65, 8811.
34. (a) Miller, C. P. Curr. Pharm. Des. 2002, 8, 2089;
35. (b) Jones, C. D.; Jevnikar, M. G.; Pike, A. J.; Peters, M. K.; Black, L. J.; Thompson, A. R.; Falcone, J. F.; Clements, J. A. J. Med. Chem. 1984, 27, 1057;
36. (c) Jordan, V. C. J. Med. Chem. 2003, 46, 883;
37. (d) Jordan, V. C. J. Med. Chem. 2003, 46, 1081.
38. Carillo-Munoz, A. J.; Giusiano, G.; Ezkurra, P. A.; Quindos, G. Expert Rev. Anti. Infect. Ther. 2005, 3, 333.
39. (a) Carter, G. W.; Young, P. R.; Albert, D. H.; Bouska, J.; Dyer, R.; Bell, R. L.; Summers, J. B.; Brooks, D. W. J. Pharmacol. Exp. Ther. 1991, 256, 929;
40. (b) Summers, J. B.; Gunn, B. P.; Brooks, D. W. U.S. Patent 4,873,259, October 10 (1989).
41. (a) Williams, C. H.; Casterline, J. L.; Jacobson, K. H. Toxicol. Appl. Pharmacol. 1967, 11, 302;
42. (b) Kurtz, P. J. Pharmacol. Biochem. Behav. 1977, 6, 303.
43. (a) Boschelli, D. H.; Kramer, J. B.; Khatana, S. S.; Sorenson, R. J.; Connor, D. T.; Ferin, M. A.; Wright, C. D.; Lesch, M. E.; Imre, K.; Okonkwo, G. C.; Schrier, D. J.; Conroy, M. C.; Ferguson, E.; Woelle, J.; Saxena, U. J. Med. Chem. 1995, 38, 4597;
44. (b) Fakhr, I. M. I.; Radwan, M. A. A.; El-Batran, S.; Abd El-Salam, O. M. E.; El-Shenawy, S. M. Eur. J. Med. Chem. 2009, 44, 1718.
45. Martinez-Esparza, J.; Oficialdegui, A. M.; Perez-Silanes, S.; Heras, B.; Orus, L.; Palop, J.-A.; Lasheras, B.; Roca, J.; Mourelle, M.; Bosch, A.; Del Castillo, J.-C.; Tordera, R.; Del Rio, J.; Monge, A. J. Med. Chem. 2001, 44, 418.
46. (a) Martinez, J.; Perez, S.; Oficialdegui, A. M.; Heras, B.; Orus, L.; Villanueva, H.; Palop, J. A.; Roca, J.; Mourelle, M.; Bosch, A.; Del Castillo, J. C.; Lasheras, B.; Tordera, R.; del Rio, J.; Monge, A. Eur. J. Med. Chem. 2001, 36, 55;
47. (b) Hrib, N. J.; Jurcak, J. G.; Bregna, D. E.; Dunn, R. W.; Geyer, H. M.; Hartman, H. B.; Roehr, J. R.; Rogers, K. L.; Rush, D. K.; Szczepanik, A. M.; Szewczak, M. R.; Wilmot, C. A.; Conway, P. G. J. Med. Chem. 1992, 35, 2712.
48. Boulware, S. L.; Bronstein, J. C.; Nordby, E. C.; Weber, P. C. Antiviral Res. 2001, 51, 111.
49. Connor, D. T.; Cetenko, W. A.; Mullican, M. D.; Sorenson, R. J.; Weikert, R. J.; Adolphson, R. L.; Kennedy, J. A.; Thueson, D. O.; Wright, C. D.; Conroy, M. C. J. Med. Chem. 1992, 35, 958.
50. Boulware, S. L.; Bronstein, J. C.; Nordby, E. C.; Weber, P. C. Antiviral Res. 2001, 51, 111.
51. (a) Mitsumori, S.; Tsuri, T.; Honma, T.; Hiramatsu, Y.; Okada, T.; Hashizume, H.; Kida, S.; Inagaki, M.; Arimura, A.; Yasui, K.; Asanuma, F.; Kishino, J.; Ohtani, M. J. Med. Chem. 2003, 46, 2446;
52. (b) Bettinetti, L.; Schlotter, K.; Hubner, H.; Gmeiner, P. J. Med. Chem. 2002, 45, 4594.
53. (a) Romagnoli, R.; Baraldi, P. G.; Carrion, M. D.; Cruz-Lopez, O.; Tolomeo, M.; Grimaudo, S.; Cristina, A. D.; Pipitone, M. R.; Balzarini, J.; Brancale, A.; Hamel, E. Bioorg. Med. Chem. 2010, 18, 5114;
54. (b) Pinney, K. G.; Bounds, A. D.; Dingeman, K. M.; Mocharla, V. P.; Pettit, G. R.; Bai, R.; Hamel, E. Bioorg. Med. Chem. Lett. 1999, 9, 1081.
55. Hartough, H. D.; Meisel, S. L. Chem. Heterocycl. Compd. 1954, 7, 1.
56. Majo, V. J.; Perumal, P. T. J. Org. Chem. 1996, 61, 6523.
57. Yariv, D.; Robert M. B.; Michael E. G.; Jeremiah H. N; (Allergan, Inc., USA). U.S. Pat. Appl. Publ., 20060106088, 18 May 2006.
58. (a) Horton, D. A.; Bourne, G. T.; Smythe, M. L. Chem. Rev. 2003, 103, 893;
59. (b) Mukherjee, C.; Kamila, S.; De, A. Tetrahedron 2003, 59, 4767;
60. (c) Castle, S. L.; Buckhaults, P. J.; Baldwin, L. J.; Mckenny, J. D. J. Heterocycl. Chem. 1987, 24, 1103;
61. (d) Campaigne, E. In Comprehensive Heterocyclic Chemistry; Katritzky, A. R., Rees, C. W., Eds.; Pergamon: Oxford, 1984; 4, pp 863-934;
62. (e) Iddon, B.; Scrowston, R. M. In Advances in Heterocyclic Chemistry; Katritzky, A. R., Boulton, A. J., Eds.; Academic: New York, 1970; 11, pp 177-381;
63. (f) Kobayashi, K.; Egara, Y.; Fukamachi, S.; Konishi, H. Tetrahedron 2009, 65, 9633;
64. (g) Toguem, S. M. T.; Hussain, M.; Malik, I.; Peter Langer, A. V. Tetrahedron Lett. 2009, 50, 4962;
65. (h) Patel, M. V.; Rohde, J. J.; Gracias, V.; Kolasa, T. Tetrahedron Lett. 2003, 44, 6665;
66. (i) Cho, C. H.; Jung, D.; Larock, R. C. Tetrahedron Lett. 2010, 51, 6485.
67. Bridge, A. J.; Lee, A.; Maduakor, E. C.; Schwartz, C. E. Tetrahedron Lett. 1992, 33, 7499.
68. Yoshida, S.; Yorimitsu, H.; Oshima, K. Org. Lett. 2007, 9, 5573.
69. Kobayashi, K.; Horiuchi, M.; Fukamachi, S.; Konishi, H. Tetrahedron 2009, 65, 2430.
70. (a) Scrowston, R. M. Adv. Heterocycl. Chem. 1981, 29, 171;
71. (b) Iddon, B. In New Trends in Heterocyclic Chemistry; Mitra, R. B., Ed.; Elsevier: Amsterdam, 1979; p 250.
72. Larock, R. C.; Yue, D. Tetrahedron Lett. 2001, 42, 6011.
73. Kost, A. N.; Budylin, V. E.; Matveeva, E. D.; Sterligov, D. O. Zh. Org. Khim. 1970, 6, 1503.
74. Sasaki, T.; Hayakawa, K.; Nishida, S. Tetrahedron 1982, 38, 75.
75. Ester, K.; Hranjec, M.; Piantanida, I.; Caleta, I.; Jarak, I.; Pavelic, K.; Kralj, M.; Karminski-Zamola, G. J. Med. Chem. 2009, 52, 2482.
76. 3 (0.5 mol) was added drop wise and allowed stirring for 10 min. The temperature was increased to 80°C and after completion of reaction (monitored by TLC) the mixture was poured into ice cold sodium acetate (0.2 mol) solution and the solid was filtered out and purified by column chromatography using ethyl acetate/petroleum ether mixture (3:1 v/v) to to yield pure 2a-h.
77. 2S: C, 52.99; H, 3.11%. Found C, 52.94; H, 3.05.
78. Crystallographic data (excluding structure factors) for compound 2g in this letter have been deposited with the Cambridge Crystallographic Data Centre as supplementary publication number CCDC 817499. Copies of the data can be obtained, free of charge, on application to CCDC, 12 Union Road, Cambridge CB2 1EZ, UK [fax: +44 (0)1223 336033 or e-mail: deposit@ccdc.cam.ac.uk].
79. Krubsack, A. J. Tetrahedron Lett. 1973, 2, 125.
80. Campaigne, E.; Cline, R. E. J. Org. Chem. 1956, 21, 39.